Option Care Health Q2 2024 GAAP EPS $0.30 Beats $0.28 Estimate, Sales $1.227B Beat $1.170B Estimate
Portfolio Pulse from Benzinga Newsdesk
Option Care Health reported Q2 2024 GAAP EPS of $0.30, beating the estimate of $0.28. Sales were $1.227 billion, surpassing the estimate of $1.170 billion.
July 31, 2024 | 11:04 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Option Care Health reported better-than-expected Q2 2024 results with GAAP EPS of $0.30 and sales of $1.227 billion, both surpassing analyst estimates.
The company's better-than-expected earnings and sales figures are likely to positively impact its stock price in the short term as it indicates strong financial performance.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100